Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Terry Moore

Terry Moore


Associate Professor, College of Pharmacy - Pharmaceutical Sciences
Director of Graduate Studies, College of Pharmacy - Pharmaceutical Sciences

Contact

Address:

833 S. Wood St. MC 781, Chicago, IL

About Heading link

Overview:
Terry W. Moore is an Associate Professor and the Director of Graduate Studies in the Department of Pharmaceutical Sciences at the University of Illinois at Chicago. His research program focuses on designing, synthesizing, and characterizing new small molecule and peptide probes to modulate a number of different protein targets. Dr. Moore’s lab at UIC uses the tools of synthetic medicinal chemistry, peptide chemistry, drug discovery and chemical biology. Dr. Moore is extensively involved in the national and international medicinal chemistry community. Dr. Moore is a Topic editor at ACS Medicinal Chemistry Letters and has served as a guest editor at Molecular and Cellular Endocrinology. He has served on the Long-Range Planning committee of the American Chemical Society Division of Medicinal Chemistry and has been on the steering committees of national and international conferences in medicinal chemistry. Dr. Moore was named the UIC “Rising Star” Researcher of the Year for the Basic Life Sciences in 2018.

Research Interests:
Drug Discovery; medicinal chemistry; peptide chemistry

Teaching Statement:
Dr. Moore teaches in the PharmD and PhD program in Pharmaceutical Sciences curricula at UIC. He is the Director of Graduate Studies for Pharmaceutical Sciences and the Concentration Coordinator for Chemistry in Drug Discovery.

Dr. Moore teaches in several team-taught courses, including PHAR 422: Fundamentals of Drug Action I; PSCI 530: Principles of Medicinal Chemistry; PSCI 531: Spectroscopy in Pharmaceutical Sciences; PSCI 501: Drug Discovery, Design and Development.

He mentors junior faculty, research faculty, postdocs, graduate students, and undergraduate students.

Teaching and Supervision Heading link

Fundamentals of Drug Action I (PHAR 422), 8/23/2022 – 12/15/2022
Medicinal Chemistry (PSCI 530), 1/10/2022 – 4/29/2022
PSCI Ph.D. Thesis Research (PSCI 599), 1/10/2022 – 4/29/2022
Pharm Sciences Rotation (PSCI 592), 1/10/2022 – 4/29/2022
Doctoral Restch in Med Chem (MDCH 599), 1/10/2022 – 4/29/2022
Fundamentals of Drug Action I (PHAR 422), 8/23/2021 – 12/15/2021
Doctoral Restch in Med Chem (MDCH 599), 8/23/2021 – 12/3/2021
Drug Discovery (PSCI 501), 8/23/2021 – 12/3/2021
PSCI Ph.D. Thesis Research (PSCI 599), 8/23/2021 – 12/3/2021

Selected Grants

Collaborative Research: OSIB: Chemical signaling in a host-microbe symbiosis, National Science Foundation., 8/15/2022 - 7/31/2025, Obligated Amount: $169997; Anticipated Amount: $249751

Novel therapeutic approaches for NPC Disease, National Institutes of Health (National Institute of Neurological Disorders and Stroke)., 7/1/2022 - 6/30/2027, Obligated Amount: $582175; Anticipated Amount: $2884491

Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics, Chicago BioSolutions Inc., 5/5/2022 - 4/30/2023, Obligated Amount: $450625; Anticipated Amount: $450625

Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action, NIH/NIAID., 2/8/2022 - 1/31/2027, Obligated Amount: $454250; Anticipated Amount: $3299182

Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action, NIH/NIAID., 2/8/2022 - 1/31/2027, Obligated Amount: $454250; Anticipated Amount: $3299182

Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action, NIH/NIAID., 7/16/2021 - 2/7/2022, Obligated Amount: $730027; Anticipated Amount: $730027

Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action, NIH/NIAID., 7/16/2021 - 2/7/2022, Obligated Amount: $730027; Anticipated Amount: $730027

Selective Antagonists of Mutant Estrogen Receptors, American Cancer Society., 7/1/2021 - 6/30/2025, Obligated Amount: $792000; Anticipated Amount: $792000

Development of 4-(aroylamino) piperidine-based entry inhibitors as anti-influenza therapeutics, Chicago BioSolutions Inc., 4/2/2021 - 3/31/2022, Obligated Amount: $150310; Anticipated Amount: $150310

Selected Publications

Ren, Pin, Tiede, Christian, Fanning, Sean W, Adams, Thomas, Speirs, Valerie, Nelson, Erik R, Cheng, Changfeng, Moore, Terry W, Greene, Geoffrey L, Tomlinson, Darren, Selvin, Paul R. (2022). Labeling of a Mutant Estrogen Receptor with an Affimer in a Breast Cancer Cell Line. Biophysical Journal. doi:10.1016/j.bpj.2022.06.028.

Naidu, Sharadha Dayalan, Dikovskaya, Dina, Moore, Terry W, Dinkova-Kostova, Albena T. (2022). Detection of thermal shift in cellular Keap1 by protein-protein interaction inhibitors using immunoblot- and fluorescence microplate-based assays. STAR Protocols, 3, (2), 101265. doi:10.1016/j.xpro.2022.101265.

Altman, Ryan A, Brai, Annalaura, Golden, Jennifer, La Regina, Giuseppe, Li, Zhengqiu, Moore, Terry W, Pomerantz, William CK, Rajapaksa, Naomi S, Adams, Ashley M. (2022). An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters. ACS Medicinal Chemistry Letters, 13, (4), 540-545. doi:10.1021/acsmedchemlett.1c00623.

Naidu, Sharadha Dayalan, Suzuki, Takafumi, Dikovskaya, Dina, Knatko, Elena V, Higgins, Maureen, Sato, Miu, Novak, Miroslav, Villegas, José A, Moore, Terry W, Yamamoto, Masayuki, Dinkova-Kostova, Albena T. (2021). The isoquinoline PRL-295 increases the thermostability of Keap1 and disrupts its interaction with Nrf2. iScience, 25, (1), 103703. doi:10.1016/j.isci.2021.103703.

Moore, Terry W. (2021). In This Issue, Volume 12, Issue 8. ACS Medicinal Chemistry Letters, 12, (8), 1181-1182. doi:10.1021/acsmedchemlett.1c00395.

Amaya, Moushimi, Cheng, Han, Borisevich, Viktoriya, Navaratnarajah, Chanakha K, Cattaneo, Roberto, Cooper, Laura, Moore, Terry W, Gaisina, Irina N, Geisbert, Thomas W, Rong, Lijun, Broder, Christopher C. (2021). A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery. Antiviral Research, 193, 105084. doi:10.1016/j.antiviral.2021.105084.

Horie, Yuta, Suzuki, Takafumi, Inoue, Jin, Iso, Tatsuro, Wells, Geoffrey, Moore, Terry W, Mizushima, Tsunehiro, Dinkova-Kostova, Albena T, Kasai, Takuma, Kamei, Takashi, Koshiba, Seizo, Yamamoto, Masayuki. (2021). Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism. Communications Biology, 4, (1), 576. doi:10.1038/s42003-021-02100-6.

Zink, Katherine E, Ludvik, Denise A, Lazzara, Phillip R, Moore, Terry W, Mandel, Mark J, Sanchez, Laura M. (2021). A Small Molecule Coordinates Symbiotic Behaviors in a Host Organ. mBio, 12, (2), e03637-e03620. doi:10.1128/mbio.03637-20.

Baliga, Chetana, Brown, Tyler J, Florin, Tanja, Colon, Sarah, Shah, Vallari, Skowron, Kornelia J, Kefi, Amira, Szal, Teresa, Klepacki, Dorota, Moore, Terry W, Vázquez-Laslop, Nora, Mankin, Alexander S. (2021). Charting the sequence-activity landscape of peptide inhibitors of translation termination. Proceedings of the National Academy of Sciences of the United States of America, 118, (10), e2026465118. doi:10.1073/pnas.2026465118.

Professional Leadership

Long-Range Planning Committee of ACS MEDI Division, American Chemical Society, 2018 - 2020

AACR Chemistry in Cancer Research, 2016 - 2019

MIKI meeting-in-miniature, 2014 - 2015

Notable Honors

2020, PhLAMEs Mentor of the Year,

2018, UIC “Rising Star” award,

2018, MEDI Young Investigator Symposium Awardee, ACS National Meeting,

2017, UIC College of Pharmacy Vahlteich Research Award,

2014, UIC College of Pharmacy P1 Teacher of the Semester,

2014, American Association of Colleges of Pharmacy New Investigator Award,

2011, The Anthony Shuker Scientific Poster Award,

2011, Emory Head and Neck Cancer SPORE Career Development Award,

2005, Pfizer Fellowship Supporting Diversity in Organic Chemistry,

Education

Degrees:
Ph.D., University of Illinois at Urbana-Champaign, United States, 2008
B.A. in Biochemistry, Abilene Christian University, United States, 2000

Postgraduate Training:
Postdoc, Emory Institute for Drug Development, United States, 2013
Postdoc, University of Illinois at Urbana Champaign, United States, 2009

Selected Presentations

Moore, Terry. (2022 March 06). Development of Isoquinoline-based Non-electrophilic NRF2 Activators. Scientific Conference of the Faculty of Pharmacy Tanta University. Cairo Egypt (hybrid).